Dorsey Wright & Associates Mersana Therapeutics, Inc. Transaction History

Dorsey Wright & Associates

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$5.65 - $7.86 $16,882 - $23,485	2,988 New	2,988 $17,000
Q4 2020 Jan 28, 2021	SELL	$16.84 - $27.59 $15,896 - $26,044	-944 Closed	0 $0
Q3 2020 Oct 28, 2020	SELL	$16.2 - $25.7 $5,103 - $8,095	-315 Reduced 25.02%	944 $18,000
Q1 2020 Apr 20, 2020	BUY	$4.41 - $9.28 $5,552 - $11,683	1,259 New	1,259 $7,000

130

104M

58.5K

471K

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $56.4M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

Stay updated on Dorsey Wright & Associates with notifications on news.